Trial record 1 of 2 for:    PSK breast cancer seattle
Previous Study | Return to List | Next Study

Vaccine Therapy With or Without Polysaccharide-K in Treating Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01922921
Recruitment Status : Active, not recruiting
First Posted : August 14, 2013
Last Update Posted : October 2, 2017
National Cancer Institute (NCI)
Office of Cancer Complementary and Alternative Medicine
Information provided by (Responsible Party):
University of Washington

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : March 31, 2018
  Study Completion Date : No date given